Vivos (RDGL) Assets Average (2011 - 2025)
Vivos recorded quarterly Assets Average of $2.1 million in Q4 2025, down 17.91% quarter-over-quarter from $2.5 million in Q3 2025, and up 19.7% year-over-year from $1.7 million in Q4 2024.
Vivos' Assets Average history runs 15 years deep, the most recent figure standing at $2.1 million for Q4 2025.
- In Q4 2025, Assets Average rose 19.7% year-over-year to $2.1 million; the TTM figure through Dec 2025 stood at $2.1 million (up 19.7% YoY), while the FY2025 annual figure was $2.1 million, up 6.7% from the prior year.
- Assets Average came in at $2.1 million for Q4 2025 at Vivos, down from $2.5 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $3.0 million in Q2 2025 to a low of $1.2 million in Q2 2022.
- A 5-year average of $1.9 million and a median of $1.7 million in 2021 frame the typical range for Assets Average.
- Across the five-year window, Assets Average surged 1096.37% in 2021 and sank 49.16% in 2022, its largest moves.
- Vivos' Assets Average stood at $1.8 million in 2021, then advanced by 3.01% to $1.9 million in 2022, then declined by 16.16% to $1.6 million in 2023, then grew by 9.48% to $1.7 million in 2024, then rose by 19.7% to $2.1 million in 2025.
- According to Business Quant data, Assets Average over the past three periods registered $2.1 million, $2.5 million, and $3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.42 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.64 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.49 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.02 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.66 Bn |
| 10 | Vivos | - | - | -3,105.00 | 2.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.08 Mn |
| Sep 30, 2025 | 2.54 Mn |
| Jun 30, 2025 | 3.04 Mn |
| Mar 31, 2025 | 2.77 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.58 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.68 Mn |
| Jun 30, 2023 | 1.63 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 1.47 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 2.14 Mn |
| Jun 30, 2021 | 2.38 Mn |
| Mar 31, 2021 | 1.73 Mn |
| Dec 31, 2020 | 497,721.00 |
| Sep 30, 2020 | 178,731.00 |
| Dec 31, 2019 | 120,465.50 |
| Sep 30, 2019 | 122,672.50 |
| Jun 30, 2019 | 52,803.00 |
| Mar 31, 2019 | 36,902.50 |
| Dec 31, 2018 | 14,108.50 |
| Sep 30, 2018 | 9,946.00 |
| Jun 30, 2018 | 4,423.00 |
| Mar 31, 2018 | 8,191.00 |
| Dec 31, 2017 | 22,621.50 |
| Sep 30, 2017 | 203,243.50 |
| Jun 30, 2017 | 201,009.00 |
| Mar 31, 2017 | 33,536.50 |
| Dec 31, 2016 | 59,635.00 |
| Sep 30, 2016 | 77,250.00 |
| Jun 30, 2016 | 197,123.00 |
| Mar 31, 2016 | 285,642.00 |
| Dec 31, 2015 | 168,848.50 |
| Sep 30, 2015 | 93,395.00 |
| Jun 30, 2015 | 91,471.50 |
| Mar 31, 2015 | 85,054.50 |
| Dec 31, 2014 | 122,528.50 |
| Sep 30, 2014 | 232,099.50 |
| Jun 30, 2014 | 307,544.00 |
| Mar 31, 2014 | 253,850.00 |
| Dec 31, 2013 | 362,006.50 |
| Sep 30, 2013 | 491,816.00 |
| Jun 30, 2013 | 610,583.50 |
| Mar 31, 2013 | 966,203.00 |
| Dec 31, 2012 | 996,227.50 |
| Sep 30, 2012 | 853,041.00 |
| Jun 30, 2012 | 927,997.50 |
| Mar 31, 2012 | 1.04 Mn |
| Dec 31, 2011 | 1.17 Mn |
| Sep 30, 2011 | 1.35 Mn |